Nilsine Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Nilsine Partners’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Buy	28,057 +937	+3%	+$32.6K	0.07%	221
2026 Q1	$908K	Buy	+27,120	New	+$927K	0.07%	222
2023 Q2	–	Sell	-43,186	Closed	-$1.13M	–	349
2023 Q1	$1.13M	Buy	+43,186	New	+$1.16M	0.18%	152

Other funds holding FTXH

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Nilsine Partners's FTXH Position: Q2 2026 in Review

Nilsine Partners increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 3.5% in Q2 2026, buying an estimated $32.6K and bringing the position to 28,057 shares worth $1.07M. The position accounts for 0.07% of the portfolio, ranked #221.

Nilsine Partners first reported a position in FTXH in Q1 2023 and has held it in 3 quarters since. The position peaked at $1.13M in Q1 2023. 7 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Nilsine Partners held 28,057 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.07M as of Q2 2026.
Nilsine Partners bought 937 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $32.6K.
First Trust Nasdaq Pharmaceuticals ETF made up 0.07% of Nilsine Partners's portfolio in Q2 2026, its #221 holding.
Nilsine Partners first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2023 and has held it in 3 quarters since.
Nilsine Partners's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.13M in Q1 2023.
7 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.